Taras, Pendatun G.

HRN: 04-14-41  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
CEFUROXIME 1.5GM (VIAL)
10/02/2024
10/09/2024
IV
1g
Q12
Decibitus Ulcer Sacral Area
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: